Skip to content

European New Texture Implant Clinical Experience With Shaped Breast Implants

European New Texture Implant Clinical Experience With Shaped Breast Implants

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01639755
Enrollment
19
Registered
2012-07-13
Start date
2012-06-18
Completion date
2017-10-16
Last updated
2017-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Augmentation

Brief summary

The purpose of this study is to obtain clinical experience with the use of new texture, shaped breast implants in bilateral primary breast augmentation.

Interventions

DEVICEnew texture shaped breast implants

breast implant surgery

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be willing to undergo bilateral breast augmentation with subglandular, submuscular, or biplanar placement of the breast implants by inframammary approach only * Be a candidate for the device styles and sizes available in the study

Exclusion criteria

* Have tuberous breasts, congenital anomalies of the breast (e.g., Poland's Syndrome), or grade 3 ptosis * Have undergone any previous breast surgery * Have tissue covering determined inadequate or unsuitable by the surgeon

Design outcomes

Primary

MeasureTime frameDescription
Investigator Overall Satisfaction With the Device Using a 5-Point Scale3 monthsThe investigator evaluated the overall satisfaction with the device using a 5-point scale where 1=definitely dissatisfied with the device to 5=definitely satisfied with the device.

Secondary

MeasureTime frameDescription
Subject Satisfaction With Breasts Using the BREAST-Q Questionnaire6 monthsParticipants evaluated satisfaction with their breasts using the BREAST-Q. Summary scores were computed by summing the score of each response and transferring them to a 0 (worst) to 100 (best) scale.
Investigator Evaluation of Whether the Implant is Palpably Distinguishable From the Tissue6 monthsThe investigator examined the breasts and evaluated whether the implant was palpably distinguishable from the tissue using a 5-point scale where 1=implant very easy to distinguish from the tissue to 5=implant indistinguishable from the tissue.
Percentage of Participants With Capsular Contracture Evaluated by Four-Grade Baker ScaleInterim analysis: 12 monthsThe investigator evaluated capsular contracture (lining of cells formed around the device as the body's response to a foreign object) using the Four-Grade Baker scale where: Grade I= Breast is normally soft and looks natural, Grade II= Breast is a little firm but looks normal, Grade III=Breast is firm and looks abnormal or Grade IV= Breast is hard, painful, and looks abnormal. The percentage of participants in each Baker Grade is reported.
Percentage of Participants With Local ComplicationsInterim analysis: 12 monthsThe percentage of participants experiencing local complications (in the area of the implant) is reported.

Countries

Sweden

Participant flow

Participants by arm

ArmCount
All Participants
Al participants who had new texture shaped breast implants surgically implanted.
19
Total19

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyPatient had device explantation4
Overall StudyStudy Ongoing15

Baseline characteristics

CharacteristicAll Participants
Age, Continuous29.3 years
STANDARD_DEVIATION 9.57
Sex: Female, Male
Female
19 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
19 / 19
serious
Total, serious adverse events
2 / 19

Outcome results

Primary

Investigator Overall Satisfaction With the Device Using a 5-Point Scale

The investigator evaluated the overall satisfaction with the device using a 5-point scale where 1=definitely dissatisfied with the device to 5=definitely satisfied with the device.

Time frame: 3 months

Population: Full analysis population included all participants.

ArmMeasureValue (MEAN)Dispersion
All ParticipantsInvestigator Overall Satisfaction With the Device Using a 5-Point Scale4.6 score on a scaleStandard Deviation 0.77
Secondary

Investigator Evaluation of Whether the Implant is Palpably Distinguishable From the Tissue

The investigator examined the breasts and evaluated whether the implant was palpably distinguishable from the tissue using a 5-point scale where 1=implant very easy to distinguish from the tissue to 5=implant indistinguishable from the tissue.

Time frame: 6 months

Population: Full analysis population included all participants.

ArmMeasureValue (MEAN)Dispersion
All ParticipantsInvestigator Evaluation of Whether the Implant is Palpably Distinguishable From the Tissue2.5 score on a scaleStandard Deviation 0.77
Secondary

Percentage of Participants With Capsular Contracture Evaluated by Four-Grade Baker Scale

The investigator evaluated capsular contracture (lining of cells formed around the device as the body's response to a foreign object) using the Four-Grade Baker scale where: Grade I= Breast is normally soft and looks natural, Grade II= Breast is a little firm but looks normal, Grade III=Breast is firm and looks abnormal or Grade IV= Breast is hard, painful, and looks abnormal. The percentage of participants in each Baker Grade is reported.

Time frame: Interim analysis: 12 months

Population: Participants from the Full Analysis population with data available for analysis.

ArmMeasureGroupValue (NUMBER)
All ParticipantsPercentage of Participants With Capsular Contracture Evaluated by Four-Grade Baker ScaleBaker Grade II11.1 percentage of participants
All ParticipantsPercentage of Participants With Capsular Contracture Evaluated by Four-Grade Baker ScaleBaker Grade I88.9 percentage of participants
All ParticipantsPercentage of Participants With Capsular Contracture Evaluated by Four-Grade Baker ScaleBaker Grade III0.0 percentage of participants
All ParticipantsPercentage of Participants With Capsular Contracture Evaluated by Four-Grade Baker ScaleBaker Grade IV0.0 percentage of participants
Secondary

Percentage of Participants With Local Complications

The percentage of participants experiencing local complications (in the area of the implant) is reported.

Time frame: Interim analysis: 12 months

Population: Full analysis population included all participants.

ArmMeasureGroupValue (NUMBER)
All ParticipantsPercentage of Participants With Local ComplicationsBreast pain100.0 percentage of participants
All ParticipantsPercentage of Participants With Local ComplicationsImplant malposition15.8 percentage of participants
Secondary

Subject Satisfaction With Breasts Using the BREAST-Q Questionnaire

Participants evaluated satisfaction with their breasts using the BREAST-Q. Summary scores were computed by summing the score of each response and transferring them to a 0 (worst) to 100 (best) scale.

Time frame: 6 months

Population: Full analysis population included all participants.

ArmMeasureValue (MEAN)Dispersion
All ParticipantsSubject Satisfaction With Breasts Using the BREAST-Q Questionnaire87.1 score on a scaleStandard Deviation 16.95

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026